Views & Analysis | Perspectives on pharma industry issues

Oncology

Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Market Access

Sponsored

The pre-commercial case for connecting data before acquiring...

For EBPs, launch requires a data strategy that starts with agreement on the KPIs, and those depend on the therapeutic areas.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Patients

pharmaphorum podcast Episode 281 - Cecilia Caetano, Bayer

Sponsored

Menopause is an urgent global health issue: Bayer’s Cecilia ...

Articles

Executive perspectives: John Castellani

With the US pharma market also feeling the winds of change, Paul Tunnah speaks with PhRMA CEO John Castellani to hear his views on the future for the industry. As one of the most influential figures in pharma it is notable that Castellani is a relative newcomer to the sector, having taken the lead role at The Pharmaceutical Research…

Articles

China – a huge opportunity but where to start?

Flic Gabbay explores the pharmaceutical business opportunities in China in our R&D innovation focus month. “Everybody knows they must be in China – but few know why they must be in China,” Dr Jingwu Zang, Senior Vice...

Articles

Cutting the price tag of clinical trials with risk-based mon...

Rick Morrison of Comprehend Systems presents the benefits to pharma associated with risk-based monitoring. On-site monitoring is a significant expense for pharmaceutical and biotech sponsors, accounting for up to 30 percent of the...

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Sales & Marketing

Female pharmacist with male patient in pharmacy

Your DTP programme has five vendors and no spine

Over the past few years, many pharma brands set out to build a direct-to-patient (DTP) channel. The website went live. A telehealth partner was selected. Pharmacy logistics were set up.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Digital